Diagnostic Criteria for Nephrotic Syndrome
Nephrotic syndrome is defined by the presence of heavy proteinuria (≥3.5 g/day in adults or ≥40 mg/m²/h in children), hypoalbuminemia (<3.0 g/dL in adults or <2.5 g/dL in children), and edema. 1
Core Diagnostic Criteria
For Adults:
Proteinuria:
Hypoalbuminemia:
- <3.0 g/dL 1
Edema:
- Typically periorbital (more noticeable in the morning)
- Dependent pitting edema (more common later in the day) 2
For Children:
Proteinuria:
Hypoalbuminemia:
- ≤2.5 g/dL 1
Note: While the 2021 KDIGO guideline suggested changing the definition to <3.0 g/dL for children, the KDOQI commentary recommends maintaining the traditional ≤2.5 g/dL threshold due to lack of evidence supporting this change. 1
Associated Features
These are commonly present but not required for diagnosis:
Hyperlipidemia:
Lipiduria 4
Increased risk of thromboembolism:
Increased susceptibility to infections 6
Diagnostic Approach
Quantify proteinuria:
- 24-hour urine collection for total protein
- Spot urine protein:creatinine ratio (PCR) or albumin:creatinine ratio (ACR)
- In children, spot UPCR has replaced 24-hour collections due to good correlation and ease of collection 1
Measure serum albumin:
- Be aware of assay differences (bromocresol green vs. bromocresol purple) when interpreting results 1
Evaluate for underlying cause:
Special Considerations
Nephrotic syndrome without nephrotic-range proteinuria:
- Can occur when albumin synthesis is decreased (e.g., concurrent liver disease)
- A steady state of renal protein excretion may be reached at <3.5 g/day despite severe defects in glomerular permeability 3
Monitoring for complications:
- Thromboembolism risk assessment
- Lipid profile
- Infection surveillance 6
Treatment Implications
The diagnosis of nephrotic syndrome often guides treatment decisions:
- In children with presumed minimal change disease, glucocorticoids are first-line therapy 5
- In adults, treatment depends on the underlying cause identified by biopsy 2
- Edematous states in idiopathic nephrotic syndrome are an FDA-approved indication for prednisone 7
The diagnostic criteria are essential for determining when to initiate specific therapies, such as in membranous nephropathy where treatment is recommended when proteinuria persistently exceeds 4 g/day for at least 6 months despite conservative therapy 1.